These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26762091)

  • 1. [Supramolecular Agents for Theranostics].
    Deyev SM; Lebedenko EN
    Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeted Bifunctional Proteins and Hybrid Nanoconstructs for Cancer Diagnostics and Therapies].
    Deyev SM; Lebedenko EN
    Mol Biol (Mosk); 2017; 51(6):907-926. PubMed ID: 29271956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 4. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 5. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
    Li L; Liu H
    Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein-assisted self-assembly of multifunctional nanoparticles.
    Nikitin MP; Zdobnova TA; Lukash SV; Stremovskiy OA; Deyev SM
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5827-32. PubMed ID: 20231484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Nanomedicine - An Overview.
    Sekhon BS
    Curr Drug Targets; 2015; 16(13):1407-28. PubMed ID: 25090984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
    Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
    Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into the engineering of green carbon dots: Possible applications in emerging cancer theranostics.
    Radnia F; Mohajeri N; Zarghami N
    Talanta; 2020 Mar; 209():120547. PubMed ID: 31892009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
    Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
    Small; 2017 Mar; 13(10):. PubMed ID: 28026115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.
    Mi P; Wang F; Nishiyama N; Cabral H
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27739631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.